Belgian-based company Janssen Pharmaceutica, owned by US pharmaceutical giant Johnson & Johnson on Tuesday submitted its COVID-19 vaccine to Europe’s medicines watchdog for conditional marketing authorisation.
“EMA has received an application for conditional marketing authorisation for COVID-19 vaccine Janssen,” the European Medicines Agency (EMA) wrote in a Twitter post on Tuesday, laying out the procedure that will follow.
A decision could be made by mid-March, “provided the company’…
This story is part of New Europe’s Premium content.
| To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑ |
In this article:
